Voyager Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease (NCT07764146) | Voyager Therapeutics | 2026-08-24 |
| VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease (NCT06874621) | Voyager Therapeutics | 2025-03-03 |
| Safety and Tolerability Study With VY-HTT01, in Adults With Early Manifesting Huntington's Disease (NCT04885114) | Voyager Therapeutics | 2021-07-30 |
Track Voyager Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.